In a recent press release, GE Healthcare and Vitrolife partner to improve assisted reproductive technology offerings.
Zipf, Austria – June 28, 2018 – In the lead up to the European Society of Human Reproduction and Embryology (ESHRE) annual conference, GE Healthcare and Vitrolife are partnering to improve patient outcomes in assisted reproductive medicine.
Infertility is a growing health issue that affects a significant number of women and couples around the world. In fact, it is estimated to affect as many as 186 million people worldwide.
More than 20 years ago, Vitrolife was a key player in introducing the technique and needles for ultrasound-guided oocyte retrieval - now a standard practice in IVF. Vitrolife’s needles feature new echomarking to maximize ultrasound visibility, and an even sharper tip to enable a smooth penetration of the tissue. GE Healthcare’s Voluson™ ultrasound systems enable physicians to monitor stimulated follicles, determine the optimal time for oocyte retrieval, and follow these needles in great detail throughout retrieval.
Editor's note: this press release originally appeared on GE Healthcare's website.
To view the full press release, click here.
News from our Partners